Published in Obesity and Diabetes Week, October 20th, 2003
The new inhaler, yet to be named, results from a March 2002 agreement both firms signed to collaborate in product development, sales, and marketing.
Omron Healthcare and Nipro are seeking business alliances with pharmaceutical companies keen to use the new inhaler for pulmonary delivery of their products. Omron Healthcare will oversee production of the inhaler's main unit and Nipro will produce and supply the cartridges to a pharmaceutical partner, or fill the cartridges.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.